Cargando…

Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs

Pneumococcal disease remains a global burden, with current conjugated vaccines offering protection against the common serotype strains. However, there are over 100 serotype strains, and serotype replacement is now being observed, which reduces the effectiveness of the current vaccines. Pneumococcal...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Figueiredo, Douglas Borges, Kaneko, Kan, Rodrigues, Tasson da Costa, MacLoughlin, Ronan, Miyaji, Eliane Namie, Saleem, Imran, Gonçalves, Viviane Maimoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230107/ https://www.ncbi.nlm.nih.gov/pubmed/35745810 http://dx.doi.org/10.3390/pharmaceutics14061238

Ejemplares similares

Evaluation of polymer choice on immunogenicity of chitosan coated PLGA NPs with surface-adsorbed pneumococcal protein antigen PspA4Pro
por: Kaneko, Kan, et al.
Publicado: (2021)

Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
por: Rodrigues, Tasson C., et al.
Publicado: (2018)

Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies
por: Oliveira, Giuliana S., et al.
Publicado: (2021)

Advancing mesenchymal stem cell therapy for asthma towards clinical translation
por: MacLoughlin, Ronan
Publicado: (2022)

Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae
por: Tostes, Rafaella O., et al.
Publicado: (2017)

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A
por: Oliveira, Maria Leonor Sarno, et al.
Publicado: (2006)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020)

State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
por: Brave, Hosanna, et al.
Publicado: (2020)

The effect of UV-protected ethylene vinyl acetate (EVA) bags on the physicochemical stability of pediatric parenteral nutrition admixtures
por: Watrobska-Swietlikowska, Dorota, et al.
Publicado: (2019)

Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate
por: Zane, Luciano, et al.
Publicado: (2023)

Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021)

Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-Colonization with Vaccine-Type and Non-Vaccine Type Pneumococci in Mice
por: Colichio, Gabriela B. C., et al.
Publicado: (2020)

In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
por: Bennett, Gavin, et al.
Publicado: (2019)

In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance
por: Bennett, Gavin, et al.
Publicado: (2018)

Cellular Therapy for the Treatment of Paediatric Respiratory Disease
por: Brennan, Laura C., et al.
Publicado: (2021)

Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy
por: Bennett, Gavin, et al.
Publicado: (2019)

A narrative review on trans-nasal pulmonary aerosol delivery
por: Li, Jie, et al.
Publicado: (2020)

Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery
por: Azhdari, Mohammad H., et al.
Publicado: (2022)

In vitro evaluation of disposable transport ventilators with combination aerosol therapy
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)

Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice
por: Choi, Sang-Yoon, et al.
Publicado: (2013)

A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
por: Chiu, Fang-Feng, et al.
Publicado: (2023)

Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021)

The Impact of Head Model Choice on the In Vitro Evaluation of Aerosol Drug Delivery
por: Gallagher, Lauren, et al.
Publicado: (2021)

Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen
por: Murphy, Barry, et al.
Publicado: (2022)

Exhaled patient derived aerosol dispersion during awake tracheal intubation with concurrent high flow nasal therapy
por: Eain, Marc Mac Giolla, et al.
Publicado: (2023)

Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era
por: Naughton, Piers J., et al.
Publicado: (2021)

Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
por: Vencken, Sebastian, et al.
Publicado: (2019)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)

In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
por: Hibbitts, Alan J., et al.
Publicado: (2020)

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
por: Joyce, Mary, et al.
Publicado: (2021)

Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy
por: McGrath, James A., et al.
Publicado: (2019)

Effective nebulization of interferon-γ using a novel vibrating mesh
por: Sweeney, Louise, et al.
Publicado: (2019)

COVID-19 in underlying COPD Patients
por: Sunkara, Krishna, et al.
Publicado: (2021)

Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
por: Hajiaghapour Asr, Mena, et al.
Publicado: (2023)

Nebulized mesenchymal stem cell derived conditioned medium ameliorates Escherichia coli induced pneumonia in a rat model
por: González, Héctor E., et al.
Publicado: (2023)

Potential role for mucosally active vaccines against pneumococcal pneumonia
por: Jambo, Kondwani C., et al.
Publicado: (2010)

Can high efficiency aerosol delivery continue after extubation?
por: Fink, J, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mml2a3sqio5faugdj840c8up7g